Working… Menu

BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02650804
Recruitment Status : Completed
First Posted : January 8, 2016
Last Update Posted : September 16, 2020
Information provided by (Responsible Party):
Berg, LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 11, 2019
Actual Study Completion Date : June 11, 2019
Certification/Extension First Submitted : September 14, 2020